ScreenerHero

SKIN SkinHealth Systems Inc. - Class A Common Stock

NAS · US · Consumer Defensive · Household & Personal Products · skinhealthsystems.com
0.6300USD0.00%Mkt Cap: 81.99M $P/E: —

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America…

Industry Peers

Household & Personal Products
Screen all
PG
The Procter & Gamble Company
$339.23BUSDP/E 22.0
OR
L'Oréal S.A.
$216.11BUSDP/E 31.7
UL
Unilever PLC
$129.17BUSDP/E 12.1
UNA
Unilever PLC
$124.25BUSDP/E 12.5
ULVR
Unilever PLC
$105.35BUSDP/E 12.2
CL
Colgate-Palmolive Company
$68.71BUSDP/E 33.9
RKT
Reckitt Benckiser Group plc
$33.69BUSDP/E 11.0
EL
The Estée Lauder Companies Inc.
$33.80BUSDP/E 186.6
KVUE
Kenvue Inc.
$33.40BUSDP/E 20.2
HEN3
Henkel AG & Co. KGaA
$31.53BUSDP/E 15.3
KMB
Kimberly-Clark Corporation - Common Stock
$31.32BUSDP/E 18.6
HEN
Henkel AG & Co. KGaA
$29.00BUSDP/E 14.1
CHD
Church & Dwight Co., Inc.
$22.69BUSDP/E 30.7
BEI
Beiersdorf Aktiengesellschaft
$17.99BUSDP/E 17.6
ESSITY-B
Essity AB (publ)
$16.53BUSDP/E 14.4
ESSITY-A
Essity AB (publ)
$16.49BUSDP/E 14.4
PUIG
Puig Brands, S.A.
$10.92BUSDP/E 17.3
CLX
The Clorox Company
$9.92BUSDP/E 17.0
ELF
e.l.f. Beauty, Inc.
$6.12BUSDP/E 105.9
IPAR
Interparfums, Inc. - Common Stock
$3.65BUSDP/E 21.8

Key Statistics

Company
Market Cap81.99M USD
Enterprise Value244.96M USD
Revenue (TTM)290.05M USD
Gross Profit196.36M USD
Net Income (TTM)-9.52M USD
Revenue/Share2.27 USD
Last Price0.6300 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees613
CountryUS
SectorConsumer Defensive
IndustryHousehold & Personal Products
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)3.32
PEG0.93
EV/EBITDA12.20
EV/Revenue0.84
P/S0.28
P/B1.48
EPS (TTM)-0.23
EPS (Forward)0.19
52W Range
0.55104% of range2.560
52W High2.560 USD
52W Low0.5510 USD
Profitability
Gross Margin65.28%
Oper. Margin4.95%
EBITDA Margin6.92%
Profit Margin-3.16%
ROE-15.59%
ROA-1.90%
Growth
Revenue Growth-7.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF37.48M USD
CapEx (TTM)5.16M USD
FCF Margin9.47%
FCF Yield33.51%
Net Debt162.97M USD
Net Debt/EBITDA8.12
Balance Sheet
Debt/Equity6.20
Current Ratio1.75
Quick Ratio1.33
Book Value/Sh0.43 USD
Cash/Share1.57 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.9917 USD
Upside (mean)+57.4%
Target Range0.7000 USD – 1.500 USD
0.7000+57.4% to mean1.500
# Analysts6
Ownership
Shares Out.130.14M
Float55.73M
Insiders13.03%
Institutions77.17%
Short Interest
Short Ratio19.6d
Short % Float15.21%
Short % Out.5.52%
Shares Short7.18M
Short (prev mo.)7.07M
Technical
SMA 500.6736 (-6.5%)
SMA 2000.9281 (-32.1%)
Beta1.00
S&P 52W Chg14.58%
Avg Vol (30d)327.54K
Avg Vol (10d)249.81K
Technical Indicators
RSI (14)40.8
MACD-0.0168
MACD Signal-0.0121
MACD Hist.-0.0048
BB Upper0.7333 USD
BB Middle0.6733 USD
BB Lower0.6134 USD
BB Width17.79%
ATR (14)0.0455 USD
Vol Ratio (20d)0.52x